Lv1
40 积分 2024-10-25 加入
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
1天前
已完结
OA14.03 Garsorasib in KRAS G12C-Mutated Non-Small-Cell Lung Cancer: Updated Results from a Phase 2 Study
1天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
1天前
已完结
高压氧联合奥沙利铂和卡培他滨化疗对胃癌患者的疗效及血清肿瘤标志物的影响[J]
3个月前
已完结
高压氧联合奥沙利铂和卡培他滨化疗对胃癌患者的疗效及血清肿瘤标志物的影响[J]
3个月前
已关闭
[Examination about positive ratio of pollen antigens by scratch test]
3个月前
已关闭
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
7个月前
已完结
皖公网安备34019202002308
